Financial Gravity Asset Management, Inc. Axsome Therapeutics, Inc. Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	BUY	$69.39 - $97.64 $69 - $97	1 New	1 $87,000
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $208 - $292	3 New	3 $219,000
Q4 2023 Jun 26, 2024	SELL	$57.42 - $83.61 $172 - $250	-3 Closed	0 $65,000
Q4 2023 Feb 15, 2024	BUY	$57.42 - $83.61 $0 - $0	0 New	0 $0
Q3 2023 Nov 15, 2023	SELL	$69.25 - $82.21 $4,986 - $5,919	-72 Closed	0 $0
Q2 2023 Aug 08, 2023	BUY	$58.41 - $90.35 $584 - $903	10 Added 16.13%	72 $151,000
Q1 2023 May 12, 2023	SELL	$58.39 - $75.0 $875 - $1,125	-15 Reduced 19.48%	62 $50,000
Q4 2022 Feb 15, 2023	SELL	$39.94 - $79.72 $2,316 - $4,623	-58 Reduced 42.96%	77 $155,000
Q3 2022 Nov 03, 2022	BUY	$36.06 - $69.85 $4,868 - $9,429	135 New	135 $36,000
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $30 - $43	-1 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$50.63 - $73.5 $50 - $73	1 New	1 $67,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.